Prion diseases are characterized by the accumulation of an abnormal, proteinase K-resistant isoform of the prion protein, PrP Sc , which is generated by a post-translational conversion of the protease-sensitive normal cell-surface glycoprotein PrP c involving major conformational changes (Aguzzi et al., 2001; Caughey, 1994; Collinge, 2001; Prusiner, 2001) . The conversion from PrP c to PrP Sc is thought to occur at the plasma membrane or along the endocytic pathway towards the lysosome (Caughey & Raymond, 1993) . PrP Sc aggregates have been found to accumulate in secondary lysosomes (McKinley et al., 1991) . In scrapieinfected mouse brain up-regulation of several genes encoding lysosomal proteases has been described (Dandoy-Dron et al., 1998; Diedrich et al., 1991; Kopacek et al., 2000) . However, it is unclear (i) whether the observed changes occur in neuronal or non-neuronal brain cells or in both; (ii) whether such changes are direct or indirect consequences of prion infection; and (iii) whether they are mirrored by similar changes in enzyme activity. We have measured the activities of two major lysosomal cysteine proteases, cathepsins B and L, following prion infection of Neuro2a cells, a purely neuronal cell type.
Neuro2a cells (ATCC), persistently scrapie-infected mouse neuroblastoma cells (ScNB; Caughey & Raymond, 1993) and the highly susceptible Neuro2a subline D11, either uninfected ('D11') or newly infected with the Chandler strain of mouse-adapted scrapie agent ('ScD11') (Zhang et al., 2002) , were all maintained at 37 uC in 5 % CO 2 in OPTI-MEM (Life Technologies) supplemented with 10 % heat-inactivated foetal calf serum and penicillin/streptomycin. Briefly, D11 cells were isolated by cloning uninfected Neuro2a cells by limiting dilution and infecting aliquots of the resulting clonal populations with scrapie inocula (Chandler strain) according to the protocol developed by Bosque & Prusiner (2000) . The inocula for the infection of cells used in the present work were homogenates from ScNB cells, diluted 1 : 30 in culture medium (Zhang et al., 2002) . Cells were grown in the presence of inoculum for 4 days. Thereafter, cells were trypsinized, transferred to 24-well plates and grown in normal medium. Cells were used 7 weeks post-infection, by which time PrP Sc production was confirmed by cell ELISA (Zhang et al., 2002) . Cell clone ScD11 was selected for its high efficiency of PrP Sc production and the uninfected D11 parental cells were used as controls. Morphology and proliferation rate was very similar between infected and uninfected cells.
All chemicals were from Bachem Biochemica or Serva (both in Heidelberg, Germany). Cathepsin B activity was detected in a cytochemical assay using the specific synthetic substrate N-benzyloxycarbonyl-arginyl-arginine-4-methoxyb-naphthylamine (1 mM) as described previously (Dolbeare & Smith, 1977) . The fluorescent reaction product 4-methoxyb-naphthylamine was precipitated by 5-nitro-salicylaldehyde followed by microscopic evaluation.
In addition, cathepsin B and L activities were measured by a quantitative fluorometric assay as described previously (Barrett & Kirschke, 1981; Ulbricht et al., 1995) . Briefly, confluent cultures in 50 cm 2 flasks were trypsinized, washed and suspended in ice-cold lysis buffer (400 mM sodium phosphate buffer, pH 6?0, 75 mM NaCl, 4 mM EDTA-Na 2, 0?25 % Triton X-100) followed by incubation on ice for 1 h. Lysates were homogenized in a Transonic-Bath three times for 15 s each at 4 uC and centrifuged at 20 000 g for 30 min at 4 uC. The protein concentration of supernatants (cell extracts) was determined by the Bio-Rad DC assay and cell extracts were stored at 280 uC. Prior to starting the reaction, reaction buffer (for cathepsin B assays: 88 mM KH 2 PO 4 , 12 mM Na 2 HPO 4, 1?33 mM EDTA-Na 2 , 2?7 mM Lcysteine, pH 6?0; for cathepsin L assays: 100 mM sodium acetate buffer, 1 mM EDTA-Na 2 , 2 mM dithiothreitol, pH 5?5) was pre-warmed to 37 uC. Then 100 ml of cell extract diluted in lysis buffer (maximally 70-100 mg protein) was added and mixed, followed by incubation at 37 uC for 5 min. Finally 25 ml substrate solution was added. Fluorescence time scans of the reaction mixture in quantitative assays showed a practically linear course over the first 1000 s (data not shown). Based on these observations, a 15 min assay time was chosen as a standard time for all experiments. A range of protein concentrations was used in the assays in order to ensure that the reaction did not reach saturation. All reactions were run at 37 uC for 15 min in a total volume of 1 ml, in the absence or presence of cathepsin inhibitors (see below), the latter value defining the non-specific background activity to be subtracted. For cathepsin B assays, the cathepsin B-specific substrate benzyloxycarbonyl-Larginyl-L-arginyl-7-amino-4-methylcoumarine (Z-arg-arg-AMC; 5 mM) was used in conjunction with the cysteine protease inhibitor L-trans-epoxy-succinyl-leucylamido-(4-guanidino)-butane (E64; 50 mM), or, alternatively, the cathepsin B-and L-specific substrate benzyloxycarbonyl-L-phenylalanyl-L-arginyl-4-methylcoumarine (Z-phe-arg-AMC; 5 mM) was used in conjunction with the cathepsin B inhibitor L-trans-epoxy-succinyl-lle-Pro-OH propylamide (CA-074; 50 mM). To detect cathepsin L activity, the substrate Z-phe-arg-AMC (5 mM) was used in conjunction with the specific cathepsin L inhibitor benzyloxycarbonyl-Lphenylalanyl-L-phenylalanyl-diazomethylketone (Z-phe-phe-CHN 2 ; 0?5 mM) or, alternatively, in the presence of either CA-074 or E64, the difference between the two values defining cathepsin L activity. To eliminate prion infectivity in the samples before fluorescence measurements, reactions were stopped by adding 5 vols 6 M guanidine hydrochloride, 50 mM Tris/HCl, pH 7?4, and incubating for 20 min at room temperature. The fluorescent product was quantified in a fluorometer (Hitachi-2000; Ex 370 nm, Em 460 nm) and standardized with amino-methylcumarine. One unit of enzyme activity represents 1 mmol substrate turned over min 21 .
In the cytochemical assay, fluorescence signals resulting from cathepsin B activity became visible in uninfected Neuro2a cells by 90 min of incubation with substrate, whereas in the persistently infected cells they were already detectable by 30 min, with a time-dependent further increase in intensity (Fig. 1) . In order to see whether or not this apparent increase in cellular cathepsin B activity in the infected cells was the result of generally increased protein content per cell under conditions of infection, we next performed quantitative fluorometric assays in cell lysates and normalized the enzyme activity data for total protein content. These fluorometric assays revealed significant increases in cathepsin B and also in cathepsin L activity in ScNB cells compared with uninfected Neuro2a cells (Fig. 2  A, B) .
To avoid any artefacts when comparing uninfected with persistently infected cells due to the commonly performed recloning of the latter to select for producer cells (Bosque & Prusiner, 2000) , we also performed cathepsin assays on newly infected cells from a highly susceptible Neuro2a subline (Zhang et al., 2002 ) that we had isolated according to a published protocol (Bosque & Prusiner, 2000) and the respective uninfected cells. In this system, very similar, significant increases in cathepsin B and L activities were found in the infected cells (Fig. 2C, D) .
Furthermore, additional assays of cathepsin B were performed using substrate Z-phe-arg-AMC in conjunction with the inhibitor CA-074 (E) and also of cathepsin L using the substrate Z-phe-arg-AMC in the presence of either CA-074 or E64 (F). Again, the data yielded the same pattern, i.e. significantly elevated cathepsin B and L activities in the infected cells, but the absolute cathepsin L activity values were lower than with the previous assay design, indicating superior specificity for cathepsin L.
The up-regulation of cathepsin activities in neuronal cells following prion infection described here may have important consequences for both pathogenesis and agent replication. Lysosomal hydrolases seem to play a role both in necrosis (Yamashima, 2000) and in the autophagic cell death described in neurons (Kegel et al., 2000) . On the other hand, cathepsin B has been implicated in the caspase cascade in apoptosis (Guicciardi et al., 2000; Ishisaka et al., 1999; Kingham & Pocock 2001; Lotem & Sachs 1996; Vancompernolle et al., 1998) , and apoptosis appears to be the predominant type of neuronal cell death in prion diseases (Fairbairn et al., 1994; Forloni et al., 1993; Giese et al., 1995; Gray et al., 1999) . In view of the above, the possible role of up-regulation of cathepsin activity in the pathogenesis of prion disease merits further study.
Lysosomotropic agents and cysteine protease inhibitors are reported to block PrP Sc accumulation in scrapie-infected Fig. 2 . Cathepsin activities in uninfected Neuro2a (N2a) compared with persistently scrapie-infected ScNB cells (ScNB) (A, B) and in uninfected (D11) compared with newly prion-infected (ScD11) cells (C, D and E, F) of the highly susceptible Neuro2a-subline N2a-D11. Cathepsin B activity was detected using the substrate Z-arg-arg-AMC in conjunction with the cysteine protease inhibitor E64 (A, C), whereas cathepsin L activity was detected using substrate Z-phe-arg-AMC in conjunction with the cathepsin L-specific inhibitor Z-phe-phe-CHN 2 (B, D). In a set of additional experiments performed on the newly infected cell system, an alternative assay design was used. Here cathepsin B was detected using substrate Z-phearg-AMC in conjunction with the cathepsin B-specific inhibitor CA-074 (E), whereas cathepsin L was detected using the same substrate in the presence of either CA-074 or E64, with the difference between the latter two values defining cathepsin L activity (F). For details see text. Values are given as mean±SD. The number (n) of parallel determinations of enzyme activity is given. Statistical analysis was performed using the Student's t-test.
neuroblastoma cells (Doh-ura et al., 2000) . Viewing these results together with our present data, we hypothesize that lysosomal proteases might be actively involved in PrP Sc formation, which would represent a 'second autocatalytic loop' in prion replication, acting in concert with the first, i.e. the well-known autocatalytic enhancement of PrP conversion in the presence of PrP Sc (Fig. 3) . A possible function for up-regulated cathepsin activities with respect to prion replication might be to disrupt large aggregates of PrP Sc , thus creating an expanded population of 'converting units', analogous to the sonication step in the 'in vitro proteinmisfolding cyclic amplification' procedure (Saborio et al., 2001) .
How the up-regulation of cathepsin B and L activities by prion infection is mediated is unknown. One intriguing possibility is the involvement of glycosaminoglycans. On the one hand, PrP Sc amyloid is known to contain sulfated glycosaminoglycans, which suggests that these may play an essential role in PrP Sc formation or stabilization (Snow et al., 1990) . Depending on the circumstances, sulfated glycans can either be cofactors (Wong et al., 2001) or inhibitors Caughey et al., 1991) of PrP Sc formation. On the other hand, there is evidence that glycosaminoglycans are involved in the in vivo processing of lysosomal cysteine proteases (Rozman et al., 1999; Ishidoh & Kominami, 1995) and in cathepsin B regulation (Almeida et al., 2001 ). Whether or not PrP Sc -associated glycosaminoglycans indeed play a role in the up-regulation of cathepsin activity in scrapie-infected cells shown in the present work requires further investigation. 
